-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tenax Therapeutics, Raises Price Target to $34

Benzinga·03/16/2026 12:49:25
Listen to the news
Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and raises the price target from $25 to $34.